Non-covalent inhibitors of the 20S proteasome

被引:1
|
作者
García-Echeverría, C [1 ]
Imbach, P [1 ]
Roesel, J [1 ]
Fuerst, P [1 ]
Lang, M [1 ]
Guagnano, V [1 ]
Noorani, M [1 ]
Zimmermann, J [1 ]
Furet, P [1 ]
机构
[1] Novartis Pharma AG, Oncol Res, CH-4002 Basel, Switzerland
关键词
antitumor agents; drug design; enzyme inhibitors; peptidomimetic;
D O I
10.2533/000942903777679415
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Peptidomimetics have been commonly used as lead compounds to design inhibitors with high affinity and specificity for a particular enzyme. The discovery that a 2-aminobenzylstatine derivative originally designed to target an aspartyl protease was able to inhibit specifically and non-covalently the chymotrypsin-like activity of the 20S proteasome represented a unique starting point for our medicinal chemistry endeavor for this target. Utilizing a structure-based design approach, we have been able to improve the potency of this new class of proteasome inhibitors without affecting its in vitro selectivity profile.
引用
收藏
页码:179 / 181
页数:3
相关论文
共 50 条
  • [11] Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome
    Blackburn, Christopher
    Barrett, Cynthia
    Blank, Jonathan L.
    Bruzzese, Frank J.
    Bump, Nancy
    Dick, Lawrence R.
    Fleming, Paul
    Garcia, Khristofer
    Hales, Paul
    Hu, Zhigen
    Jones, Matthew
    Liu, Jane X.
    Sappal, Darshan S.
    Sintchak, Michael D.
    Tsu, Christopher
    Gigstad, Kenneth M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6581 - 6586
  • [12] Structural elucidation of recombinant Trichomonas vaginalis 20S proteasome bound to covalent inhibitors
    Silhan, Jan
    Fajtova, Pavla
    Bartosova, Jitka
    Hurysz, Brianna M.
    Almaliti, Jehad
    Miyamoto, Yukiko
    Eckmann, Lars
    Gerwick, William H.
    O'Donoghue, Anthony J.
    Boura, Evzen
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [13] Synthesis of bimodal inhibitors of the 20S proteasome
    Jamali, Haya
    Steiner, Stephanie
    Tomlin, Frederick
    Goldfogel, Matthew
    Gotz, Marion G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [14] Nostocyclopeptides as New Inhibitors of 20S Proteasome
    Fidor, Anna
    Cekala, Katarzyna
    Wieczerzak, Ewa
    Ceglowska, Marta
    Kasprzykowski, Franciszek
    Edwards, Christine
    Mazur-Marzec, Hanna
    BIOMOLECULES, 2021, 11 (10)
  • [15] A class of non-competitive inhibitors for 20S proteasome.
    Wang, L
    Joly, A
    Meyer, S
    Lum, RT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U213 - U213
  • [16] Optimization of a series of dipeptides with a P3 β-neopentyl asparagine residue as non-covalent inhibitors of the chymotrypsin-like activity of human 20S proteasome
    Blackburn, Christopher
    Barrett, Cynthia
    Blank, Jonathan L.
    Bruzzese, Frank J.
    Bump, Nancy
    Dick, Lawrence R.
    Fleming, Paul
    Garcia, Khristofer
    Hales, Paul
    Jones, Matthew
    Liu, Jane X.
    Nagayoshi, Masayuki
    Sappal, Darshan S.
    Sintchak, Michael D.
    Tsu, Christopher
    Xia, Cindy
    Zhou, Xiansi
    Gigstad, Kenneth M.
    MEDCHEMCOMM, 2012, 3 (06) : 710 - 719
  • [17] Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit (vol 430, pg 461, 2010)
    Blackburn, C.
    Gigstad, K. M.
    Hales, P.
    Garcia, K.
    Jones, M.
    Bruzzese, F. J.
    Barrett, C.
    Liu, J. X.
    Soucy, T. A.
    Sappal, D. S.
    Bump, N.
    Olhava, E. J.
    Fleming, P.
    Dick, L. R.
    Tsu, C.
    Sintchak, M. D.
    Blank, J. L.
    BIOCHEMICAL JOURNAL, 2010, 431 : 433 - 433
  • [18] Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome.: Application to structure-based analogue design
    Furet, P
    Imbach, P
    Fürst, P
    Lang, M
    Noorani, M
    Zimmermann, J
    Garcia-Echeverría, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (10) : 1321 - 1324
  • [19] Identification of a new series of amides as non-covalent proteasome inhibitors
    Scarbaci, Kety
    Troiano, Valeria
    Micale, Nicola
    Ettari, Roberta
    Tamborini, Lucia
    Di Giovanni, Carmen
    Cerchia, Carmen
    Grasso, Silvana
    Novellino, Ettore
    Schirmeister, Tanja
    Lavecchia, Antonio
    Zappala, Maria
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 76 : 1 - 9
  • [20] Crystal structure of the 20 S proteasome: TMC-95A complex: A non-covalent proteasome inhibitor
    Groll, M
    Koguchi, Y
    Huber, R
    Kohno, J
    JOURNAL OF MOLECULAR BIOLOGY, 2001, 311 (03) : 543 - 548